Workflow
Corcept Therapeutics (CORT) Tops Q2 Earnings Estimates

Corcept Therapeutics (CORT) came out with quarterly earnings of 0.29pershare,beatingtheZacksConsensusEstimateof0.29 per share, beating the Zacks Consensus Estimate of 0.23 per share. This compares to earnings of 0.32pershareayearago.Thesefiguresareadjustedfornonrecurringitems.Thisquarterlyreportrepresentsanearningssurpriseof+26.090.32 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +26.09%. A quarter ago, it was expected that this drug developer would post earnings of 0.17 per share when it actually produced earnings of $0.17, delivering no surprise.Over the last four quarters, the comp ...